Relevant BNF section: 4.8.1
Up to 30% of patients with epilepsy have seizures resistant to available treatments.1 We consider here the place of ▼tiagabine (Gabitril - Sanofi-Synthelabo), which was recently introduced as an "add-on therapy for partial seizures with or without secondary generalisation where control is not achieved by optimal doses of at least one other anti-epileptic ".2
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.